Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
South Korea Extends Bond Market Stabilization Measures Amid Rising Financial Risks 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Japan Business Sentiment Hits Four-Year High, Boosting Expectations of BOJ Rate Hike 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand 
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen 
China’s Small Bank Consolidation Struggles as Profits Fall and Risks Persist 
An Abbott Laboratories processing plant in Sturgis, Mich being investigated for cases of infant illness is being allowed to release some product that was processed before it was shut down.
Certain goods designed for infants and people with specific medical issues will be given out for free.
Abbott officials claimed they're doing it at the FDA's request to help with shortages of these specialty feeding items.
After a recall of Similac infant formula and other products in February, the Sturgis plant was forced to shut down. Cronobacter bacteria had infected many infants, one of whom died; cronobacter was identified in their systems and the formula they had drunk. Cronobacter bacteria were discovered in the factory during an inspection.
However, further examination revealed that the cronobacter strain that caused the infections was not the same as the one detected in the plant and that no food-contact surfaces had been contaminated.
On a case-by-case basis, Abbott is issuing cases of a nutrition supplement for people with uncommon metabolic diseases and others. The corporation stated that it is doing so at the FDA's request to assist reduce shortages.
